Skin pigmentation after NB-UVB and three analogues of prostaglandin F 2α in guinea pigs: A comparative study

Journal of the European Academy of Dermatology and Venereology

Volumn 24, Issue 1, 2010, Pages 28-31

  Anbar, T S ^a   El Ammawi, T S ^a   Barakat, M ^a   Fawzy, A ^a  

^a MINIA UNIVERSITY   (Egypt)

Author keywords

Melanogenesis; Prostaglandin F2 analogues; Vitiligo

Indexed keywords

BIMATOPROST; EOSIN; HEMATOXYLIN; LATANOPROST; TRAVOPROST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEPIGMENTATION; DRUG EFFECT; EXPERIMENTAL GUINEA PIG; FEMALE; HISTOPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; SKIN BIOPSY; SKIN PIGMENTATION; ULTRAVIOLET B RADIATION;

AMIDES; ANIMALS; CLOPROSTENOL; FEMALE; GUINEA PIGS; PROSTAGLANDINS F, SYNTHETIC; SKIN PIGMENTATION; ULTRAVIOLET RAYS;

EID: 71949098667     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2009.03346.x     Document Type: Article

References (21)

1. Bolognia JL, Pawelek JM. Biology of hypopigmentation. J Am Acad Dermatol 1988 19 : 217 255.
2. Etzel RA, Balk SJ, Bearer CF, Miller MD. Ultraviolet light: a hazard to children. Newsl Am Acad Pediatr 1999 104 : 328 333.
3. Köster W, Wiskemann A. Phototherapy with UV-B in vitiligo. Z Hautkr 1990 65 (11 1022 1024.
4. Westerhof W, Nieuweboer-Krobotova L. Treatment of vitiligo with UV-B radiation vs. topical psoralen plus UV-A. Arch Dermatol 1997 133 : 1525 1528.
5. Nicolas JF, Chamchick N, Thivolet J, Wijdenes J, Morel P, Revillard JP. CD4 antibody treatment of severe psoriasis. Lancet 1991 3 338 (8762 321.
6. Karvonen J, Kokkonen E, Ruotsalainen E. 311 nm UVB lamps in the treatment of psoriasis with the Ingram regimen. Acta Derm Venereol 1989 69 (1 82 85.
7. Walters I. Suberythematogenic narrow-band UVB is markedly more effective than conventional UVB in treatment of psoriasis vulgaris. J Am Acad Dermatol 1990 40 : 893 900.
8. Pentland A, Mahoney M. Keratinocyte prostaglandin synthesis is enhanced by IL-1. J Invest Dermatol 1990 94 : 43 46.
9. Parsad D, Pandhi R, Dogra S, Kumar B. Topical prostaglandin analogue (PGE2) in vitiligo - a preliminary study. Int J Dermatol 2002 41 : 942 945.
10. Kapoor R, Phiske MM, Jerajani HR. Evaluation of safety and efficacy of topical prostaglandin E2 in treatment of vitiligo. Br J Dermatol 2009 160 : 861 863.
11. Alexander CL, Miller SJ, Abel SR. Prostaglandin analog treatment of glaucoma and ocular hypertension. Ann Pharmacother 2002 36 (3 504 511.
12. Eisenberg DL, Toris CB, Camras CB. Bimatoprost and travoprost: a review of recent studies of two new glaucoma drugs. Surv Ophthalmol 2002 47 (1 S105 S115.
13. Wand M, Ritch R, Isbey EK, Zimmerman TJ. Latanoprost and periocular skin color changes. Arch Ophthalmol 2001 119 : 614 615.
14. Kapur R, Osmanovic S, Toyran S, Edward DP. Bimatoprost-induced periocular skin hyperpigmentation: histopathological study. Arch Ophthalmol 2005 123 : 1541 1546.
15. Protocol of hematoxylin and eosin staining of tissue sections. Rosenlab Website. http://www.bcm.edu/rosenlab/protocols.html accessed July 2008.
16. Masson P. The Masson-Fontana method for melanin. C R Acad Sci (Paris) 1914 158 : 57.
17. Quoted from Drury RAB and Wallington EA. Pigments. In : Drury RAB, Wallington EA, eds. Carleton's Histological Technique, 5th edn. Oxford University Press, Oxford, 1980 : 260.
18. El-Mofty AM. Vitiligo and Psoralen. Pergamon Press, Oxford. 1968 : 147.
19. Halder RM, Young CM. New and emerging therapies of vitiligo. Dermatol Clin 2000 18 : 79 89.
20. Duval C, Laurent-Teluob S, Schmidt R. UV triggers the release of keratinocytes-derived prostaglandins which stimulate melanin synthesis: inhibitory effect of anti-inflammatory drugs. Pigment Cell Res 2004 17 (5 577.
21. Imokawa G. Autocrine and paracrine regulation of melanocytes in human skin and in pigmentary disorders. Pigment Cell Res 2004 17 : 96 110.